Literature DB >> 2475891

Tachykinin-induced vasodilatation in rat skin measured with a laser-Doppler flowmeter: evidence for receptor-mediated effects.

P V Andrews1, R D Helme.   

Abstract

Vasodilatation was induced by perfusion of the tachykinins substance P (SP), neurokinin A and neurokinin B and the analogues [Glp6, D-Pro9]SP-(6-11) and [Glp6, L-Pro9]SP-(6-11) over the base of vacuum-induced blisters on the rat footpad. Vasodilatation was measured as change in blood flow using a laser-Doppler flowmeter. The tachykinins induced vasodilatation in a dose-response manner with a threshold of approximately 3 pmol and pD2's of 6.48, 6.13 and 6.21 for SP, neurokinin A and neurokinin B respectively. The D- and L-Pro analogues of [Glp6, Pro9]SP-(6-11) also induced vasodilatation in a dose-dependent manner. The L-Pro analogue was more potent than the D-Pro analogue (D/L ratio of the EC50's = 21) which suggests the involvement of an NK-1 type receptor in the mediation of small vessel vasodilatation. The vasodilatation to SP was reduced by 64% and 59% in capsaicin- and antihistamine-pretreated animals respectively, demonstrating the involvement of capsaicin-sensitive primary afferent nerves and mast cells in the vasodilatation component of the neurogenic inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475891     DOI: 10.1016/0167-0115(89)90175-4

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  3 in total

Review 1.  Role of neurogenic inflammation in pancreatitis and pancreatic pain.

Authors:  Louis Vera-Portocarrero; Karin N Westlund
Journal:  Neurosignals       Date:  2005

2.  Effects of interactions of naturally-occurring neuropeptides on blood flow in the rat knee joint.

Authors:  F Y Lam; W R Ferrell
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

3.  Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo.

Authors:  J M Hall; S D Brain
Journal:  Br J Pharmacol       Date:  1994-10       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.